Esmolol for the Treatment of Hypertension After Intracerebral Hemorrhage Study (ETHICHS)

NCT03743103 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Low enrollement

Conditions

Hemorrhagic Stroke

Interventions

DRUG: Brevibloc, 10 Mg/mL Intravenous Solution
DRUG: Nitroprusside, Sodium

Sponsor

Cristália Produtos Químicos Farmacêuticos Ltda.